Delcath Systems Overview

  • Founded
  • 1987
Founded
  • Status
  • Public
  • Employees
  • 30
Employees
  • Stock Symbol
  • DCTH
Stock Symbol
  • Share Price
  • $12.54
  • (As of Thursday Closing)

Delcath Systems General Information

Description

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Diagnostic Equipment
Therapeutic Devices
Stock Exchange
NAS
Primary Office
  • 1633 Broadway
  • 22nd Floor, Suite C
  • New York, NY 10019
  • United States
+1 (212) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Delcath Systems Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.54 $12.72 $5.15 - $95.87 $48.8M 3.89M 79.6K -$576.76

Delcath Systems Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 34,184 (11,655) (3,610) 17,703
Revenue 1,569 1,580 3,407 2,715
EBITDA (4,830) (2,344) (10,819) (23,104)
Net Income (7,163) (8,879) (19,222) (45,117)
Total Assets 20,443 14,212 6,844 8,887
Total Debt 2,525 2,861 2,038 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Delcath Systems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Delcath Systems‘s full profile, request access.

Request a free trial

Delcath Systems Executive Team (8)

Name Title Board Seat Contact Info
Jennifer Simpson Ph.D Chief Executive Officer & Board Member
John Purpura Chief Executive Officer
Barbra Keck Secretary, Administration
You’re viewing 3 of 8 executive team members. Get the full list »

Delcath Systems Board Members (9)

Name Representing Role Since
00000 000000 Delcath Systems Board Member 000 0000
00000000 0000000 00.0 Delcath Systems Chief Executive Officer & Board Member 000 0000
00000 00000 00.0 Delcath Systems Chairman & Board Member 000 0000
0000000 00000000 Self Board Member 000 0000
You’re viewing 4 of 9 board members. Get the full list »

Delcath Systems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delcath Systems Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Delcath Systems‘s full profile, request access.

Request a free trial